Circulating Cell-free DNA Fragmentomics Detection and Beyond
Circulating cell-free DNA (cfDNA) comprises DNA fragments released into bodily fluids via apoptosis, necrosis, or phagocytosis. cfDNA encapsulates both fragmentomics (structural) and non-fragmentomics (sequence/epigenetic) information from source cells, thereby representing a promising biomarker.
Tianliang, Liu +3 more
exaly +3 more sources
Multidimensional roles of cfDNA fragmentomics in preeclampsia: from placental hypoxia and TLR9 inflammation to clinical risk stratification [PDF]
Cell-free DNA (cfDNA) has emerged as a pivotal biomarker for predicting preeclampsia (PE), a multisystem syndrome characterized by placental hypoperfusion and systemic inflammation.
Ziyi Guo, Bin Zhang, Di Yang, Li Wang
doaj +2 more sources
Cell-free DNA fragmentomics for preeclampsia risk assessment
Preeclampsia (PE) is a pregnancy-specific hypertensive disorder that could lead to serious maternal and fetal complications, yet early identification of women at risk remains challenging because reliable biomarkers are limited.
Wenqiu Xu +39 more
doaj +2 more sources
Comprehensive fragmentation of cell-free repetitive DNA for enhanced cancer detection in plasma [PDF]
BackgroundRepetitive elements account for a large proportion of the human genome and undergo alterations during early tumorigenesis. However, the exclusive fragmentation pattern of DNA-derived cell-free repetitive elements (cfREs) remains unclear ...
Mingguang Zhang +7 more
doaj +2 more sources
Fragmentomic liquid biopsy enables early breast cancer detection, molecular subtyping and lymph node assessment [PDF]
Breast cancer remains a leading global health concern in women, while screening is still limited by imaging accessibility and reduced sensitivity in dense breasts.
Yuxuan Zhu +26 more
doaj +2 more sources
Fragmentomics of urinary cell-free DNA in nuclease knockout mouse models.
Urinary cell-free DNA (ucfDNA) is a potential biomarker for bladder cancer detection. However, the biological characteristics of ucfDNA are not well understood.
Meihui Chen +18 more
doaj +3 more sources
GUIDE: a prospective cohort study for blood-based early detection of gastrointestinal cancers using targeted DNA methylation and fragmentomics sequencing [PDF]
Background Gastrointestinal (GI) cancers are among the most prevalent and lethal malignancies worldwide. Early, non-invasive detection is essential for timely intervention and improved survival.
Ao Huang +28 more
doaj +2 more sources
DeepFRAG: a method for cancer detection based on DNA fragmentomics and deep learning. [PDF]
Abstract Motivation Cancer screening using liquid biopsy technology has become standard in modern clinical and preventive oncology. This method analyzes cell-free DNA (cfDNA) circulating in a patient’s bloodstream.
Koch A, Giladi E.
europepmc +4 more sources
Fragmentomics features of cell free DNA in eating disorders
Eating disorders are lacking reliable biomarkers despite their severe psychiatric and medical burden. In this study, we examined plasma cell-free DNA (cfDNA) from patients with the restrictive (ANR), or binge–purge (ANBP) subtypes of anorexia nervosa, as
Alisa Burova +8 more
doaj +2 more sources
Early detection, clinicopathological subtyping, and prognosis prediction for endometrial cancer patients using fragmentomics liquid biopsy assay [PDF]
Peng He, Wanxiangfu Tang, Misi He
exaly +2 more sources

